#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma Hepatocellular carcinoma Breast angiosarcoma Methylmalonic acidaemia Cystic fibrosis lung Langerhans' cell histiocytosis Stevens-Johnson syndrome Allogenic stem cell transplantation Cholangiosarcoma Soft tissue necrosis Glioma Waldenstrom's macroglobulinaemia Primary amyloidosis Epstein-Barr virus associated lymphoproliferative disorder Short stature homeobox gene mutation More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Treatment Sarcoidosis – Diagnostics Paroxysmal nocturnal haemoglobinuria – Diagnostics Haemophilia B with anti factor IX – Basic Information Soft tissue sarcoma – Trials in Disease Factor IX deficiency Primary immunodeficiency syndrome – Treatment Synovial sarcoma – Treatment Undifferentiated sarcoma – Trials in Disease Leukoencephalopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chloride Ion Nefopam Clenbuterol Hydrochloride Regn7075 GSKVX000000070965 ILOPROST Cefalexin Monohydrate Ceralasertib ARTICAINE HYDROCHLORIDE Oxitriptan Oditrasertib Denosumab L-Threonine HEMOPEXIN, HUMAN Calcium Levofolinate Pemetrexed Ecoo4 Diclofenac Epolamine Pegargiminase Meldonium More therapies…

    Learn about Your Condition

    Orthostatic hypotension Keratosis follicular Brain stem glioma Pancreaticoduodenectomy Malignant fibrous histiocytoma Malignant melanoma stage IV Aneurysm ruptured Pneumonia bacterial Ewing's sarcoma metastatic Hypercholesterolaemia Krabbe's disease Testis cancer Fibromyalgia Carpal tunnel syndrome Pulmonary resection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Desmoid tumour

  • Study of Nirogacestat in adult premenopausal women with desmoid tumors and aggressive fibromatosis to evaluate ovarian function recovery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Desmoid tumour
    Investigated Drugs:
    • Nirogacestat Hydrobromide
    Belgium Germany Italy The Netherlands Spain
  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant glioma
    • Desmoid tumour
    • Neoplasm malignant
    Investigated Drugs:
    • Propranolol Hydrochloride
    • Vinorelbine Tartrate
    France
  • Study of varegacestat (AL102) in patients with progressing desmoid tumors

    Not recruiting

    4 1
    Investigated Drugs:
    • Varegacestat
    Belgium Germany Italy The Netherlands Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!